Literature DB >> 22832500

Adverse effects of antiepileptic drugs.

Piero Perucca1, Frank G Gilliam.   

Abstract

More than 150 years after bromide was introduced as the first antiepileptic drug, adverse effects remain a leading cause of treatment failure and a major determinant of impaired health-related quality of life in people with epilepsy. Adverse effects can develop acutely or many years after starting treatment and can affect any organ or structure. In the past two decades, many efforts have been made to reduce the burden of antiepileptic drug toxicity. Several methods to screen and quantify adverse effects have been developed. Patient profiles associated with increased risk of specific adverse effects have been uncovered through advances in the areas of epidemiology and pharmacogenomics. Several new-generation antiepileptic drugs with improved tolerability profiles and reduced potential for drug interaction have been added to the therapeutic armamentarium. Overall, these advances have expanded the opportunities to tailor treatment with antiepileptic drugs, to enhance effectiveness and minimise the risk of toxic effects.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832500     DOI: 10.1016/S1474-4422(12)70153-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  117 in total

Review 1.  Optogenetics enlightens neuroscience drug discovery.

Authors:  Chenchen Song; Thomas Knöpfel
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

2.  Patient-Reported Adverse Effects Associated with Combination Antiretroviral Therapy and Coadministered Enzyme-Inducing Antiepileptic Drugs.

Authors:  Melissa A Elafros; Gretchen L Birbeck; Joseph C Gardiner; Omar K Siddiqi; Izukanji Sikazwe; Nigel Paneth; Christopher M Bositis; Jason F Okulicz
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

3.  Epilepsy: Effects of exposure to antiepileptic drugs during development.

Authors:  Frank Vajda
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

Review 4.  Genetic biomarkers in epilepsy.

Authors:  Yvonne G Weber; Anne T Nies; Matthias Schwab; Holger Lerche
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 5.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

6.  Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance.

Authors:  Rolina D van Gaalen; Michal Abrahamowicz; David L Buckeridge
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

Review 7.  Cognitive and fatigue side effects of anti-epileptic drugs: an analysis of phase III add-on trials.

Authors:  Rani A Sarkis; Yazel Goksen; Yi Mu; Bernard Rosner; Jong Woo Lee
Journal:  J Neurol       Date:  2018-07-12       Impact factor: 4.849

Review 8.  Ionic and synaptic mechanisms of seizure generation and epileptogenesis.

Authors:  Oscar C González; Giri P Krishnan; Igor Timofeev; Maxim Bazhenov
Journal:  Neurobiol Dis       Date:  2019-05-28       Impact factor: 5.996

9.  The Feasibility and Impact of the EMOVE Intervention on Self-efficacy and Outcome Expectations for Exercise in Epilepsy.

Authors:  Irene H Dustin; Barbara Resnick; Elizabeth Galik; N Jennifer Klinedinst; Kathleen Michael; Edythe Wiggs; William H Theodore
Journal:  J Neurosci Nurs       Date:  2019-04       Impact factor: 1.230

10.  Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.

Authors:  Bshra Ali A Alsfouk; Martin J Brodie; Matthew Walters; Patrick Kwan; Zhibin Chen
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.